Lanean...
A Review of Clinical Trials of Human Papillomavirus Prophylactic Vaccines
End of study analyses of the phase III trials of prophylactic human papillomavirus (HPV) virus-like particle (VLP) vaccines in young women are now largely completed. Two distinct vaccines were evaluated, Gardasil(®) (Merck & Co., Whitehouse Station, NJ USA) a quadrivalent vaccine containing VLPs...
Gorde:
| Argitaratua izan da: | Vaccine |
|---|---|
| Egile Nagusiak: | , , |
| Formatua: | Artigo |
| Hizkuntza: | Inglês |
| Argitaratua: |
2012
|
| Gaiak: | |
| Sarrera elektronikoa: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4636904/ https://ncbi.nlm.nih.gov/pubmed/23199956 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.vaccine.2012.04.108 |
| Etiketak: |
Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!
|